68 results
8-K
EX-10.1
COSM
Cosmos Health Inc
28 Nov 23
Departure of Directors or Certain Officers
4:05pm
, or in part, on the attainment of a financial reporting measure including, but not limited to:
Annual bonuses and other short- and long-term cash incentives
8-K
EX-99.1
COSM
Cosmos Health Inc
22 Nov 23
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share
9:30am
and nutraceutical products.
Notes payable (current & long-term portion) decreased by 15.9% to $4.2 million in Sep 2023 from $5.01 million in Dec 2022, while lines
8-K
EX-99.1
COSM
Cosmos Health Inc
10 Oct 23
COSMOS HEALTH CEO Issues Letter to Shareholders
4:05pm
Cosmos throughout its journey to achieve its long-term objectives. So far in 2023, my investments have amounted to approximately $850,000. Specifically
8-K
EX-99.1
COSM
Cosmos Health Inc
14 Sep 23
Other Events
5:17pm
, Chief Executive Officer of Cosmos Health, stated: “We are pleased to announce guidance based on our long-term outlook to achieve substantial growth
8-K
EX-99.1
ytxne7y4vu
15 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
4o56i c1h
18 Apr 23
Achieves Positive Adjusted EBITDA for the Fiscal Year 2022
8:35am
DEF 14A
9juj3pqv9li7jzam
20 Oct 22
Definitive proxy
4:51pm
424B3
5wtps wkbkc
19 Oct 22
Prospectus supplement
7:01pm
PRE 14A
tba858u441zasgf pf
23 Sep 22
Preliminary proxy
4:25pm
S-3
EX-1.2
dlcb4zfegbtqgi 5v
22 Sep 22
Shelf registration
9:28am